BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10657618)

  • 1. IL-4 suppression of in vivo T cell activation and antibody production.
    Morris SC; Gause WC; Finkelman FD
    J Immunol; 2000 Feb; 164(4):1734-40. PubMed ID: 10657618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo IL-4 responses to anti-IgD antibody are MHC class II dependent and beta 2-microglobulin independent and develop normally in the absence of IL-4 priming of T cells.
    Morris SC; Coffman RL; Finkelman FD
    J Immunol; 1998 Apr; 160(7):3299-304. PubMed ID: 9531287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice.
    Finkelman FD; Svetic A; Gresser I; Snapper C; Holmes J; Trotta PP; Katona IM; Gause WC
    J Exp Med; 1991 Nov; 174(5):1179-88. PubMed ID: 1940796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextran-conjugated anti-IgD antibodies inhibit T cell-mediated IgE production but augment the synthesis of IgM and IgG.
    Peçanha LM; Yamaguchi H; Lees A; Noelle RJ; Mond JJ; Snapper CM
    J Immunol; 1993 Mar; 150(6):2160-8. PubMed ID: 7680684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of antigen-specific T cell help in the generation of in vivo antibody responses. I. Antigen-specific T cell help is required to generate a polyclonal IgG1 response in anti-IgD antibody-injected mice.
    Morris SC; Lees A; Inman J; Finkelman FD
    J Immunol; 1992 Dec; 149(12):3836-44. PubMed ID: 1281190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells.
    Le Gros G; Ben-Sasson SZ; Seder R; Finkelman FD; Paul WE
    J Exp Med; 1990 Sep; 172(3):921-9. PubMed ID: 2117636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells.
    Yoshimoto T; Okamura H; Tagawa YI; Iwakura Y; Nakanishi K
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3948-53. PubMed ID: 9108085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T help requirements for the generation of an in vivo IgE response: a late acting form of T cell help other than IL-4 is required for IgE but not for IgG1 production.
    Finkelman FD; Holmes J; Urban JF; Paul WE; Katona IM
    J Immunol; 1989 Jan; 142(2):403-8. PubMed ID: 2521345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LPS-stimulated SJL macrophages produce IL-12 and IL-18 that inhibit IgE production in vitro by induction of IFN-gamma production from CD3intIL-2R beta+ T cells.
    Yoshimoto T; Nagai N; Ohkusu K; Ueda H; Okamura H; Nakanishi K
    J Immunol; 1998 Aug; 161(3):1483-92. PubMed ID: 9686615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyclonal activation of the murine immune system by an antibody to IgD. X. Evidence that the precursors of IgG1-secreting cells are newly generated membrane IgD+B cells rather than the B cells that are initially activated by anti-IgD antibody.
    Finkelman FD; Goroff DK; Fultz M; Morris SC; Holmes JM; Mond JJ
    J Immunol; 1990 Dec; 145(11):3562-9. PubMed ID: 2246501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgE class switching is critically dependent upon the nature of the B cell activator, in addition to the presence of IL-4.
    Snapper CM; Peçanha LM; Levine AD; Mond JJ
    J Immunol; 1991 Aug; 147(4):1163-70. PubMed ID: 1714474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of murine in vivo IgG and IgE responses by a monoclonal anti-IL-4 receptor antibody.
    Finkelman FD; Urban JF; Beckmann MP; Schooley KA; Holmes JM; Katona IM
    Int Immunol; 1991 Jun; 3(6):599-607. PubMed ID: 1888709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4 is required to generate and sustain in vivo IgE responses.
    Finkelman FD; Katona IM; Urban JF; Holmes J; Ohara J; Tung AS; Sample JV; Paul WE
    J Immunol; 1988 Oct; 141(7):2335-41. PubMed ID: 2459206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses.
    Finkelman FD; Katona IM; Mosmann TR; Coffman RL
    J Immunol; 1988 Feb; 140(4):1022-7. PubMed ID: 3125247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection.
    Morris SC; Madden KB; Adamovicz JJ; Gause WC; Hubbard BR; Gately MK; Finkelman FD
    J Immunol; 1994 Feb; 152(3):1047-56. PubMed ID: 7905496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Kerkvliet NI; Baecher-Steppan L; Shepherd DM; Oughton JA; Vorderstrasse BA; DeKrey GK
    J Immunol; 1996 Sep; 157(6):2310-9. PubMed ID: 8805628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of T-helper type-1 immune response against Listeria monocytogenes by treatment of mice with goat antibodies to mouse IgD.
    Matsuzaki G; Song F; Nomoto K
    Immunology; 1996 Jan; 87(1):15-20. PubMed ID: 8666428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-4 requirements for the generation of secondary in vivo IgE responses.
    Katona IM; Urban JF; Kang SS; Paul WE; Finkelman FD
    J Immunol; 1991 Jun; 146(12):4215-21. PubMed ID: 1674956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-2 inhibits IL-4-dependent IgE and IgG1 production in vitro and in vivo.
    Nakanishi K; Yoshimoto T; Chu CC; Matsumoto H; Hase K; Nagai N; Tanaka T; Miyasaka M; Paul WE; Shinka S
    Int Immunol; 1995 Feb; 7(2):259-68. PubMed ID: 7734421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCR-stimulated naive human CD4+ 45RO- T cells develop into effector cells that secrete IL-13, IL-5, and IFN-gamma, but no IL-4, and help efficient IgE production by B cells.
    Brinkmann V; Kristofic C
    J Immunol; 1995 Apr; 154(7):3078-87. PubMed ID: 7897199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.